Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12611000658910
Ethics application status
Approved
Date submitted
28/06/2011
Date registered
28/06/2011
Date last updated
9/11/2016
Type of registration
Retrospectively registered
Titles & IDs
Public title
A randomised trial comparing the effect of green-lipped mussel and glucosamine in treating osteoarthritis of the knee and assessing if this correlates to the nutraceuticals improving gut integrity
Query!
Scientific title
A Phase-I Randomised, Comparison Pilot Trial Evaluating the Efficacy of Nutraceutical Compounds in patients with Osteoarthritis of the Knee – Therapeutic Outcome Measures Correlated to Gastrointestinal Integrity.
Query!
Secondary ID [1]
262358
0
The University of Queensland HREC 2009000148
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis of the knee
268060
0
Query!
Irritable Bowel Symptoms
268061
0
Query!
Condition category
Condition code
Alternative and Complementary Medicine
268205
268205
0
0
Query!
Other alternative and complementary medicine
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Green-Lipped Mussel extract 3000mg/day
3 capsules taken orally twice per day over 12 weeks
Query!
Intervention code [1]
266751
0
Treatment: Drugs
Query!
Comparator / control treatment
Glucosamine sulphate 3000mg/day
3 capsules taken orally twice per day over 12 weeks
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
268944
0
Faecal Microbial Analysis
Query!
Assessment method [1]
268944
0
Query!
Timepoint [1]
268944
0
At baseline before supplementation and at week 12 after commencement of supplements
Query!
Primary outcome [2]
268945
0
The Western Ontario and McMaster Universities Arthritis Index (WOMAC) which measures knee pain, knee stiffness and impaired physical function due to knee osteoarthritis.
Query!
Assessment method [2]
268945
0
Query!
Timepoint [2]
268945
0
baseline and at week 6 and week 12 after commencement of supplements
Query!
Primary outcome [3]
268946
0
Gastrointestinal Symptom Rating Score (GSRS)
Query!
Assessment method [3]
268946
0
Query!
Timepoint [3]
268946
0
Baseline, week 6 and week 12
Query!
Secondary outcome [1]
276669
0
Lequesne Index questionnaire which measures knee pain, walking distance and daily living in patients with osteoarthritis of the knee.
Query!
Assessment method [1]
276669
0
Query!
Timepoint [1]
276669
0
baseline and at week 6 and week 12 after commencement of supplements
Query!
Secondary outcome [2]
276670
0
SF-12 short form Health Questionnaire
Query!
Assessment method [2]
276670
0
Query!
Timepoint [2]
276670
0
baseline and at week 6 and week 12 after commencement of supplements
Query!
Secondary outcome [3]
276891
0
Daily pain score on 5 point likert scale
Query!
Assessment method [3]
276891
0
Query!
Timepoint [3]
276891
0
daily for 12 weeks starting from first day of supplementation
Query!
Eligibility
Key inclusion criteria
- Not taking any form of herbal/multivitamin, fish oil, probiotic, glucosamine or GLM therapy within the past 2 weeks prior to the study enrolment
- Confirmed osteoarthritis of the knee(s) by appointed Rheumatologist
Query!
Minimum age
40
Years
Query!
Query!
Maximum age
80
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Concurrent use of any other investigational product(s);
- Active substance abuse (alcohol or drug dependency);
- Breastfeeding or pregnancy,
- Allergies to Shellfish (Mollusks and Crustaceans)
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation not concealed
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computerised random number generated
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 1
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
1/06/2011
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment postcode(s) [1]
4166
0
4102
Query!
Funding & Sponsors
Funding source category [1]
267324
0
Self funded/Unfunded
Query!
Name [1]
267324
0
The Centre for Integrative Clinical and Molecular Medicine, The University of Queensland
Query!
Address [1]
267324
0
The Princess Alexandra Hospital
The Centres for Health Research
Lvl 2, R wing
199 Ipswich rd
Woolloongabba, QLD, 4102
Query!
Country [1]
267324
0
Australia
Query!
Primary sponsor type
University
Query!
Name
The University of Queensland
Query!
Address
Research and Innovation Division
Cumbrae-Stewart Building (72)
St Lucia, QLD 4072
Query!
Country
Australia
Query!
Secondary sponsor category [1]
266392
0
Commercial sector/Industry
Query!
Name [1]
266392
0
Aroma NZ
Query!
Address [1]
266392
0
12 Senior Place
Bromley
Christchurch 8062
Query!
Country [1]
266392
0
New Zealand
Query!
Other collaborator category [1]
252080
0
Other Collaborative groups
Query!
Name [1]
252080
0
Bioscreen Medical
Query!
Address [1]
252080
0
Bio21 Molecular Science & Biotechnology Institute
Building 404, Room G6
2Park Drive, University of Melbourne,
Parkville, Victoria, 3010
Query!
Country [1]
252080
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
269310
0
The University of Queensland Human Research Ethics Committee
Query!
Ethics committee address [1]
269310
0
The University of Queensland
Research & Research Training Division
Cumbrae-Stewart Building (72)
St Lucia 4072
Query!
Ethics committee country [1]
269310
0
Australia
Query!
Date submitted for ethics approval [1]
269310
0
01/02/2011
Query!
Approval date [1]
269310
0
22/02/2011
Query!
Ethics approval number [1]
269310
0
2009000148
Query!
Summary
Brief summary
The purpose of the trial is to compare the efficacy of a green-lipped mussel (GLM) extract to a glucosamine sulphate preparation in patients with osteoarthritis (OA) of the knee(s) and to determine if gastrointestinal dysfunction (particularly altered gut flora) plays a role in the therapuetic outcomes. Gastrointestinal dysfunction is reported in OA patients and preliminary data has shown GLM significantly improves gut function. This comparative trial will investigate the gut flora in patients before and after supplementation to see if the nutaceuticals are therapeutically affecting gut flora and function as a mechanism of action of decreasing inflammation and improving pain and stiffness indices in OA patients.
Query!
Trial website
Query!
Trial related presentations / publications
Coulson S, Vecchio P, Masci P, Vitetta L. Green–Lipped Muscle Extract and GIT Function in Patients Diagnosed with OA of the Knee. AIMA International Integrative Conference 2009, Abstract Presentation.
Coulson S, Vecchio P, Masci O, Vitetta L. A randomized phase-I/pilot comparison trial evaluating the efficacy of nutraceutical compounds in patients with osteoarthritis of the knee – therapeutic outcome measures correlated to gastrointestinal integrity. International conference on the science of nutrition in medicine and healthcare 2011; Scientific stream and accepted abstracts, pg 80.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
32730
0
Query!
Address
32730
0
Query!
Country
32730
0
Query!
Phone
32730
0
Query!
Fax
32730
0
Query!
Email
32730
0
Query!
Contact person for public queries
Name
15977
0
Samantha Coulson
Query!
Address
15977
0
The Princess Alexandra Hospital
The Centres for health research
Lvl 2, R wing
Ipswich Rd
Woolloongabba 4102
QLD
Query!
Country
15977
0
Australia
Query!
Phone
15977
0
+61 07 3176 5273
Query!
Fax
15977
0
+61 07 3176 6858
Query!
Email
15977
0
[email protected]
Query!
Contact person for scientific queries
Name
6905
0
samantha coulson
Query!
Address
6905
0
The Princess Alexandra Hospital
The Centres for health research
Lvl 2, R wing
Ipswich Rd
Woolloongabba 4102
QLD
Query!
Country
6905
0
Australia
Query!
Phone
6905
0
+61 07 3176 5273
Query!
Fax
6905
0
+61 07 3176 6858
Query!
Email
6905
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF